Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis.
Kevin Bryan U LoRuchika BhargavGrace SalacupJerald PelayoJeri AlbanoPeter A McCulloughJanani RangaswamiPublished in: Expert review of cardiovascular therapy (2020)
use of ACEI/ARB was not associated with increased mortality or severe COVID-19.